The project, which included UB’s Center for Integrated Global Biomedical Sciences, aims to keep hospitals and schools clean from viruses, microbial growth.
Waheed Adedeji will soon launch a clinical trial in Nigeria, exploring the pharmacokinetic interaction between the antidepressant fluoxetine and the antiviral drug Dolutegravir, which fights HIV.